Frankfurt/Main | November 07, 2011
euromicron AG adopts capital increase with subscription rights from authorized capital
The Executive Board of euromicron AG decided on November 7, 2011, with the consent of the Supervisory Board from November 7, 2011, to increase the capital stock of the company by up to €3.931,620.00 from €13,105,397.44 to up to €17,037,017.44 in exchange for cash contributions and using the authorized capital in accordance with Section 5 (4) of the company’s Articles of Association. Up to 1,537,800 new registered shares will be issued at an amount of about €2.56 per share and with full entitlement to a share in profits as of January 1, 2011 (“new shares”).
As part of subscription to the new shares, equinet Bank AG has been authorized and obligated to offer the new shares to shareholders of euromicron AG in the ratio 10 to 3 by way of an indirect subscription right at the price of €16.00 per new share. The subscription period is expected to commence on November 15, 2011, and ends on (and including) November 28, 2011. There will be no organized trading of the subscription rights. The company will give all shareholders the opportunity to participate in the capital increase by acquiring additional shares above and beyond the subscription rights to which they are entitled. More details can be found in the offer for subscription, which is expected to be published in the Electronic Federal Official Gazette and on the company’s Website on November 11, 2011.
The company may receive total gross cash proceeds of up to about €24.6 million from the offering. The proceeds from the capital increase are part of the framework for financing the company’s growth and innovation program for new products and systems, and essentially serve to bolster our capital structure, strengthen the equity ratio and reduce borrowings. As a result, the company increases its financial flexibility for the next stage of its corporate strategy.
The offer to subscribe to shares of euromicron AG is not public. It is addressed solely to existing shareholders of euromicron AG.